Trans American Aquaculture (GRPS) Cash from Financing Activities (2023 - 2025)
Trans American Aquaculture (GRPS) reported Cash from Financing Activities of $44000.0 for Q3 2025, up 34.54% on a YoY basis from $32705.0 in Q3 2024, and down 93.41% quarter-over-quarter from $667912.0 in Q2 2025.
Trans American Aquaculture (GRPS) Cash from Financing Activities (2023 - 2025) Analysis & Trends
Trans American Aquaculture has reported Cash from Financing Activities for 3 years, with the latest figure at $44000.0 in Q3 2025.
- For the quarter ending Q3 2025, Cash from Financing Activities rose 34.54% year-over-year to $44000.0; the trailing twelve-month figure through Sep 2025 stood at -$3.4 million (down 625.59% YoY), and the FY2024 full-year result was -$3.7 million, down 429.94% from the prior year.
- Cash from Financing Activities for Q3 2025 stood at $44000.0, down from $667912.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $667912.0 in Q2 2025, with the low at -$4.2 million in Q4 2024.
- Historically, Cash from Financing Activities has averaged -$168525.0 across 3 years, with a median of $220977.0 in 2023.
- Annual changes were most pronounced in 2024 — Cash from Financing Activities plunged 1980.38% — and 2025, when it jumped 99.87%.
- Trans American Aquaculture's Cash from Financing Activities stood at $220977.0 in 2023, then sank by 1980.38% to -$4.2 million in 2024, then soared by 101.06% to $44000.0 in 2025.
- The last three Cash from Financing Activities figures came in at $44000.0 (Q3 2025), $667912.0 (Q2 2025), and $31784.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -840.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1.48 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -86.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -65.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.47 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -77.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -11.62 Mn |
| 10 | Trans American Aquaculture | - | - | - | 44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 44,000.00 |
| Sep 30, 2025 | 44,000.00 |
| Jun 30, 2025 | 667,912.00 |
| Jun 30, 2025 | 667,912.00 |
| Mar 31, 2025 | 31,784.00 |
| Mar 31, 2025 | 31,784.00 |
| Dec 31, 2024 | -4.16 Mn |
| Dec 31, 2024 | -4.16 Mn |
| Sep 30, 2024 | 32,705.00 |
| Sep 30, 2024 | 32,705.00 |
| Jun 30, 2024 | 334,178.00 |
| Jun 30, 2024 | 334,178.00 |
| Mar 31, 2024 | 61,219.00 |
| Mar 31, 2024 | 61,219.00 |
| Dec 31, 2023 | 220,977.00 |
| Dec 31, 2023 | 220,977.00 |
| Sep 30, 2023 | 398,657.00 |
| Sep 30, 2023 | 398,657.00 |
| Jun 30, 2023 | 245,844.00 |
| Jun 30, 2023 | 245,844.00 |